000 01422 a2200397 4500
005 20250514064723.0
264 0 _c20030516
008 200305s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.11304
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuckner, Jan C
245 0 0 _aIrinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.
_h[electronic resource]
260 _bCancer
_cMay 2003
300 _a2352-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIrinotecan
700 1 _aReid, Joel M
700 1 _aWright, Keith
700 1 _aKaufmann, Scott H
700 1 _aErlichman, Charles
700 1 _aAmes, Matthew
700 1 _aCha, Steve
700 1 _aO'Fallon, Judith R
700 1 _aSchaaf, Lawrence J
700 1 _aMiller, Langdon L
773 0 _tCancer
_gvol. 97
_gno. 9 Suppl
_gp. 2352-8
856 4 0 _uhttps://doi.org/10.1002/cncr.11304
_zAvailable from publisher's website
999 _c12503533
_d12503533